Navellier & Associates Inc. lessened its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 28.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,618 shares of the biopharmaceutical company’s stock after selling 5,872 shares during the quarter. Navellier & Associates […] Read this story